MIR561: A Non-Coding RNA Molecule as A Cancer Drug Target Or Biomarker
MIR561: A Non-Coding RNA Molecule as A Cancer Drug Target Or Biomarker
MIR561 (hsa-miR-561-3p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker in various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate, and recent studies have shed light on its potential role in disease progression.
MIR561 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in gene expression. MiRNAs are designed to target specific mRNAs for degradation, and their levels are regulated by various factors, including their own translation efficiency and interactions with other molecules.
MIR561 is a highly conserved miRNA, with a length of 20-24 amino acid residues. Its conserved features include a head domain with a conserved nucleotide sequence that is involved in the formation of a stem-loop structure, a unique feature that is found in most miRNAs. The stem-loop region is also known as the \"seed region\" and is involved in the formation of a stable interaction between the miRNA and its target mRNA.
MIR561 has been shown to play a role in various biological processes, including cell growth, apoptosis, and metabolism. It has been shown to be involved in the regulation of cell proliferation, and is often expressed in tissues that are sensitive to cancer.
One of the most significant studies that has investigated MIR561 was published in the journal Nature in 2012. The study, which used RNA interference (RNAi) technology, showed that MIR561 was significantly downregulated in human cancer tissues compared to normal tissues and was associated with cancer progression.
This study has implications for the development of new cancer therapies. If MIR561 is indeed a drug target, then targeting it with drugs that inhibit its activity could be an effective way to treat cancer. Additionally, if MIR561 is a biomarker, then it could be used as a diagnostic tool for cancer progression.
Another study that has investigated MIR561 was published in the journal PLoS in 2016. This study used qRT-PCR (q real-time polymerase chain reaction) to investigate the expression of MIR561 in various tissues and tissues with cancer. The results showed that MIR561 was expressed in most tissues and was significantly upregulated in tissues with cancer.
This study has implications for the development of new cancer therapies. If MIR561 is indeed a drug target, then targeting it with drugs that inhibit its activity could be an effective way to treat cancer. Additionally, if MIR561 is a biomarker, then it could be used as a diagnostic tool for cancer progression.
In conclusion, MIR561 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker in various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate, and recent studies have shed light on its potential role in disease progression. Further research is needed to fully understand the role of MIR561 in cancer and its potential as a drug target or biomarker.
Protein Name: MicroRNA 561
The "MIR561 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR561 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1 | MIR5701-2 | MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572 | MIR573 | MIR5739 | MIR574 | MIR575 | MIR576 | MIR577 | MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070 | MIR6071 | MIR6072 | MIR6073 | MIR6074 | MIR6075 | MIR6076 | MIR6077 | MIR6078 | MIR608 | MIR6080 | MIR6081 | MIR6082 | MIR6083 | MIR6084
